<DOC>
	<DOCNO>NCT02551367</DOCNO>
	<brief_summary>110 infertile woman diagnose polycystic ovary syndrome ( PCOS ) age group 20-35 distribute randomly : - 55 woman receive letrozole 2.5mg twice daily orally 2nd day 6thday cycle three successive cycle . - 55 woman receive clomiphene citrate 50 mg twice daily orally 2nd day 6thday cycle three successive cycle . Patients subject : Complete history taking : 1 . Details name , age 2 . Menstrual history determination menarche 3 . Amenorrhea oligomenorrhea , Regularity cycle 4 . History endocrine disease . 5 . History previous operation . - Physical examination : - General examination : With special concern : -- Acne . -- Hirsutism . -- Weight . -- Height -- BMI determine : Wt . kg ـــــــــــــــــــ = ) Height ) 2 - Abdominal examination : - scar previous pelvic abdominal operation . - Pelvic examination : - vaginal examination enlarge cystic ovary . - ultrasound diagnosis pcos . PARAMETERS : ( 1 ) rate ovulation ( primary parameter ) . ( 2 ) serum progesterone level day 21 . ( 3 ) number mature follicle produce per cycle . ( 4 ) mean endometrial thickness . ( 6 ) chemical pregnancy . ( 7 ) ongoing pregnancy</brief_summary>
	<brief_title>Letrozole Versus Clomiphene Citrate Ovulation Induction Women With Poly Cystic Ovary Syndrome ( PCOS )</brief_title>
	<detailed_description>The aim study compare efficacy letrozole ovulation induction clomiphene citrate woman suffer polycystic ovary syndrome . Research question : In woman PCOS , dose letrozole effective ovulation induction clomiphene citrate ? Researcher hypothesis : In woman pcos , letrozole may effective clomiphene citrate ovulation induction . Patients method Site : study recruit woman attend infertility outpatient clinic Ain Shams university maternity hospital . Design : Randomized controlled trial . Study population : 110 infertile woman diagnose polycystic ovary syndrome ( PCOS ) age group 20-35 distribute randomly : - 55 woman receive letrozole 2.5mg twice daily orally 2nd day 6thday cycle three successive cycle . - 55 woman receive clomiphene citrate 50 mg twice daily orally 2nd day 6thday cycle three successive cycle . Inclusion criterion : 1 . Age 20-35 2 . Primary secondary infertility 3 . Patients diagnose PCOS accord Rotterdam criterion : Menstrual irregularity : - oligomenorrhea and/or anovulation . - Oligomenorrhea ( menses occur interval great 35 day ) - Excess androgen activity . - Clinically : hirsutism . - Biochemically : elevate serum androgen . polycystic ovary ( gynecologic ultrasound ) Exclusion criterion : Any patient cause infertility mention inclusion criterion : 1 . Hyperprolactinemia . 2 . Male factor infertility . WHO Guidelines 2010 Normal seminal fluid analysis : - Volume &gt; 1.5 ml - ph 7.2 8.0 - Liquefaction time 20 30 min - Sperms concentration &gt; 15 million/ml - Total motility 40 % ( Progressive motility + non progressive motility ) - Progressive motility 32 % - Morphology &gt; 4 % normal form 3 . Thyroid dysfunction . 4 . Diabetes Mellitus . 5 . Known suspicious tubal factor infertility ( hysteroslapingograrhy ( HSG ) laparoscope . 6 . Endometrioses pelvic inflammatory disease . Patients subject : Complete history taking : 1 . Details bout name , age 2 . Menstrual history determination menarche 3 . Amenorrhea oligomenorrhea , Regularity cycle 4 . History endocrine disease . 5 . History previous operation . Physical examination : General examination : With special concern : -- Acne . -- Hirsutism . - Weight . - Height - BMI determine : Wt . kg ـــــــــــــــــــ = ) Height ) 2 - Abdominal examination : scar previous pelvic abdominal operation . - Pelvic examination : vaginal examination enlarge cystic ovary . - ultrasound diagnosis pcos . - The patient randomly assign receive either letrozole ( 2.5 mg twice daily ) clomiphene citrate ( 50 mg twice daily ) day 2 day 6 menstrual cycle . - Follicular monitoring do transvaginal ultrasonography ( TVS ) alternate day day 9 menstrual cycle mature follicle detect . Follicle consider mature attain 18 mm size average inner two diameter follicle . - A single injection 10,000 IU human chorionic gonadotrophin ( hCG ) give , least one follicle attain 18 mm . TVS do 48 h hCG injection determine follicle rupture . If follicle find unruptured , TVS repeat 72 h hCG injection detect whether follicle rupture . Ovulation ascertain observing rupture follicle ultrasonogram ( USG ) . - Endometrial thickness 8 mm consider satisfactory response endometrium . - day 21 serum progesterone level measure . A progesterone level 10 ng/ml consider ovulatory . PARAMETERS Primary outcome measure : ( 1 ) Rate ovulation assess number mature follicle produce per cycle . Secondary outcome measure : ( 2 ) Serum progesterone level day 21 ( assess 24 week ) . ( 3 ) Mean endometrial thickness ( assessed 24 week ) . ( 4 ) Chemical pregnancy ( assessed 24 week ) . ( 5 ) Ongoing pregnancy ( assessed 24 week ) .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<mesh_term>Anovulation</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Letrozole</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . Age 2035 2 . Primary secondary infertility 3 . Patients diagnose PCOs accord Rotterdam criterion ( Rotterdam ESHRE/ASRMSponsored PCOS Consensus Workshop Group.,2003 ) Any patient cause infertility mention inclusion criterion : 1 . Hyperprolactinemia . 2 . Male factor infertility . WHO Guidelines 2010 Normal seminal fluid analysis : Volume &gt; 1.5 ml ph 7.2 8.0 Liquefaction time 20 30 min Sperms concentration &gt; 15 million/ml Total motility 40 % ( Progressive motility + non progressive motility ) Progressive motility 32 % Morphology &gt; 4 % normal form 3 . Thyroid dysfunction . 4 . Diabetes Mellitus . 5 . Known suspicious tubal factor infertility HSG laparoscope . 6 . Endometrioses pelvic inflammatory disease .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>letrozole</keyword>
</DOC>